Some libertarians oppose vaccine mandates by claiming that unvaccinated people only impose costs on themselves. However, as I noted in an earlier post, we’re all paying for the vaccine hesitancy stirred up on the right. From JAMA (footnotes omitted): Findings suggest that insurers heavily subsidized the costs of ivermectin prescriptions for COVID-19, even though economic theory holds that insurers should not cover ineffective care. Wasteful insurer spending on these prescriptions, estimated at .5 million in the week of August 13, 2021, would extrapolate to 9.7 million annually. For perspective, this total exceeds estimated annual Medicare spending on unnecessary imaging for low back pain, a low-value service that has received extensive
Topics:
Eric Kramer considers the following as important: politics
This could be interesting, too:
Robert Skidelsky writes Speech in the House of Lords – Autumn Budget 2024
Merijn T. Knibbe writes Völkermord in Gaza. Two million deaths are in the cards.
Peter Radford writes Who brought us Trump?
NewDealdemocrat writes Real GDP for Q3 nicely positive, but long leading components mediocre to negative for the second quarter in a row
Some libertarians oppose vaccine mandates by claiming that unvaccinated people only impose costs on themselves. However, as I noted in an earlier post, we’re all paying for the vaccine hesitancy stirred up on the right.
From JAMA (footnotes omitted):
Findings suggest that insurers heavily subsidized the costs of ivermectin prescriptions for COVID-19, even though economic theory holds that insurers should not cover ineffective care. Wasteful insurer spending on these prescriptions, estimated at $2.5 million in the week of August 13, 2021, would extrapolate to $129.7 million annually. For perspective, this total exceeds estimated annual Medicare spending on unnecessary imaging for low back pain, a low-value service that has received extensive attention. The true amount of waste is even higher because estimates did not include Medicaid spending. Moreover, by reducing barriers to a drug that some individuals use as a substitute for COVID-19 vaccination or other evidence-based care, insurance coverage could increase spending for COVID-19 complications.